SCHEMBL7466262

SCHEMBL7466262

CCCc1c(C(=O)C(C)C)c2ccc(C(=O)OC)cc2n1Cc1c(Cl)cccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 7/20 0.41
SLC22A12 Q96S37 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
PLA2G2A P14555 2/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP14 P54578 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RORC P51449 1/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7425401 0.91 MAPT (0.43) S1PR3ALDH1A1MAPTTSHRPLA2G2A
SCHEMBL7418558 0.89 SLC22A12 (0.50) SLC22A12RORC
SCHEMBL7476111 0.89 SLC22A12 (0.40) SLC22A12ALDH1A1PLA2G2AMEN1KMT2A
SCHEMBL7421260 0.86 S1PR3 (0.40) S1PR3MAPTMEN1KMT2AUSP14
SCHEMBL7707832 0.85 S1PR3 (0.44) S1PR3SLC22A12ALDH1A1MAPTTSHR
SCHEMBL7428559 0.84 TP53 (0.50) S1PR3MAPTPOLBSMN1; SMN2
SCHEMBL7418596 0.84 MAPT (0.38) S1PR3ALDH1A1MAPTPLA2G2AUSP14
SCHEMBL7420228 0.84 MAPT (0.38) S1PR3MAPTMEN1KMT2AUSP14
SCHEMBL7424404 0.84 S1PR3 (0.42) S1PR3ALDH1A1MAPTKDM4E
SCHEMBL7422342 0.84 S1PR3 (0.42) S1PR3ALDH1A1MAPTTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102863326-A Preparation method of antiepileptic drug intermediate Changzhou pharmaceutical factory co ltd 2013-01-09 CN claimed
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
EP-0828704-B1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER LAMBERT CO (US) 2002-03-13 EP disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0828704-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1998-03-18 EP disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
US-5629447-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-05-13 US disclosed
US-5616793-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-04-01 US disclosed
WO-1996038405-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1996-12-05 WO disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed